MACQUARIE GROUP LTD - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$13,000
-87.0%
325
-82.8%
0.00%
Q3 2022$100,000
+14.9%
1,887
-23.5%
0.00%
Q2 2022$87,000
-23.7%
2,4680.0%0.00%
Q1 2022$114,000
-95.2%
2,468
-93.0%
0.00%
-100.0%
Q4 2021$2,351,000
+7.8%
35,450
+1.4%
0.00%0.0%
Q3 2021$2,181,000
-57.5%
34,945
-43.6%
0.00%
-50.0%
Q2 2021$5,131,000
+63.6%
61,954
+31.0%
0.00%0.0%
Q1 2021$3,137,000
-26.7%
47,311
-15.1%
0.00%
-33.3%
Q4 2020$4,278,000
+133.9%
55,748
+31.2%
0.01%
+100.0%
Q3 2020$1,829,000
-6.8%
42,484
-6.5%
0.00%0.0%
Q2 2020$1,963,000
+88.8%
45,454
+25.7%
0.00%
+50.0%
Q1 2020$1,040,000
+16.3%
36,156
+156.4%
0.00%
+100.0%
Q4 2019$894,000
+22250.0%
14,100
+6950.0%
0.00%
Q3 2018$4,000
-97.4%
200
-98.2%
0.00%
Q2 2018$151,000
+22.8%
11,100
-66.8%
0.00%
Q4 2017$123,00033,4000.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,264$54,392,00033.22%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$216,228,00028.00%
L1 Capital Pty Ltd 296,024$19,629,0004.93%
Aquilo Capital Management, LLC 407,926$27,050,0004.89%
Evolutionary Tree Capital Management, LLC 72,948$4,837,0002.86%
ACUTA CAPITAL PARTNERS, LLC 108,000$7,161,0002.58%
First Light Asset Management, LLC 536,836$35,598,0002.36%
Parkman Healthcare Partners LLC 70,089$4,648,0001.08%
Hood River Capital Management LLC 357,082$23,678,0000.76%
Vanguard Capital Wealth Advisors 11,099$703,565,0000.60%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders